Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lead | 13 | 2025 | 100 | 5.590 |
Why?
|
| Lead Poisoning, Nervous System, Childhood | 6 | 2019 | 9 | 2.730 |
Why?
|
| Lead Poisoning | 5 | 2023 | 25 | 2.480 |
Why?
|
| Soil Pollutants | 3 | 2025 | 105 | 2.370 |
Why?
|
| Chromosomes, Human, Pair 22 | 8 | 2009 | 42 | 1.720 |
Why?
|
| Organometallic Compounds | 4 | 2019 | 71 | 1.640 |
Why?
|
| Dust | 2 | 2025 | 57 | 1.630 |
Why?
|
| Microglia | 3 | 2019 | 208 | 1.350 |
Why?
|
| Environmental Exposure | 4 | 2023 | 256 | 1.260 |
Why?
|
| Porphobilinogen Synthase | 3 | 2014 | 4 | 1.100 |
Why?
|
| Exploratory Behavior | 3 | 2017 | 78 | 1.040 |
Why?
|
| Soil | 2 | 2025 | 171 | 1.000 |
Why?
|
| Memory Disorders | 3 | 2016 | 77 | 0.980 |
Why?
|
| Hippocampus | 2 | 2019 | 594 | 0.920 |
Why?
|
| Environmental Monitoring | 2 | 2025 | 230 | 0.880 |
Why?
|
| Chromosome Deletion | 4 | 2009 | 53 | 0.810 |
Why?
|
| Symporters | 2 | 2014 | 15 | 0.780 |
Why?
|
| DiGeorge Syndrome | 4 | 2009 | 49 | 0.770 |
Why?
|
| Child | 15 | 2023 | 3443 | 0.700 |
Why?
|
| Lactation | 3 | 2019 | 44 | 0.700 |
Why?
|
| Child, Preschool | 11 | 2018 | 1546 | 0.670 |
Why?
|
| Gene Deletion | 3 | 2006 | 168 | 0.660 |
Why?
|
| Arsenic | 2 | 2025 | 155 | 0.660 |
Why?
|
| Water Supply | 2 | 2017 | 60 | 0.660 |
Why?
|
| Rural Population | 3 | 2018 | 373 | 0.640 |
Why?
|
| Litter Size | 1 | 2019 | 14 | 0.630 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2016 | 298 | 0.630 |
Why?
|
| Data Interpretation, Statistical | 1 | 2019 | 125 | 0.610 |
Why?
|
| Receptors, CCR7 | 1 | 2019 | 19 | 0.600 |
Why?
|
| Mice, Inbred C57BL | 7 | 2019 | 1869 | 0.580 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 863 | 0.570 |
Why?
|
| Models, Statistical | 1 | 2019 | 195 | 0.570 |
Why?
|
| Male | 24 | 2023 | 23409 | 0.550 |
Why?
|
| Developmental Disabilities | 3 | 2014 | 67 | 0.530 |
Why?
|
| Mental Recall | 1 | 2017 | 84 | 0.500 |
Why?
|
| Female | 24 | 2019 | 24698 | 0.480 |
Why?
|
| Olfactory Perception | 1 | 2015 | 6 | 0.460 |
Why?
|
| Water Pollutants, Chemical | 1 | 2017 | 171 | 0.460 |
Why?
|
| Haplotypes | 4 | 2014 | 197 | 0.450 |
Why?
|
| Maternal Exposure | 1 | 2015 | 57 | 0.440 |
Why?
|
| Paint | 2 | 2025 | 5 | 0.430 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2014 | 734 | 0.420 |
Why?
|
| Kidney Glomerulus | 1 | 2013 | 86 | 0.390 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2018 | 1124 | 0.370 |
Why?
|
| Cadmium | 2 | 2025 | 56 | 0.370 |
Why?
|
| Kidney Diseases | 1 | 2013 | 172 | 0.360 |
Why?
|
| Animals | 10 | 2020 | 16992 | 0.350 |
Why?
|
| Neuropsychological Tests | 3 | 2014 | 284 | 0.350 |
Why?
|
| Animals, Newborn | 3 | 2019 | 352 | 0.330 |
Why?
|
| Humans | 23 | 2023 | 43102 | 0.330 |
Why?
|
| Housing | 2 | 2023 | 74 | 0.320 |
Why?
|
| Attention | 3 | 2014 | 174 | 0.320 |
Why?
|
| Schizophrenia | 4 | 2004 | 93 | 0.310 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 1596 | 0.300 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2009 | 82 | 0.290 |
Why?
|
| Age Factors | 4 | 2018 | 1154 | 0.290 |
Why?
|
| Child Behavior Disorders | 1 | 2009 | 35 | 0.290 |
Why?
|
| Time Factors | 3 | 2019 | 1857 | 0.290 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 201 | 0.280 |
Why?
|
| Socialization | 2 | 2006 | 23 | 0.280 |
Why?
|
| Texas | 3 | 2018 | 457 | 0.260 |
Why?
|
| Infant | 2 | 2023 | 1175 | 0.260 |
Why?
|
| Abnormalities, Multiple | 2 | 2005 | 38 | 0.260 |
Why?
|
| Chromosome Disorders | 1 | 2006 | 8 | 0.260 |
Why?
|
| Movement Disorders | 1 | 2006 | 9 | 0.260 |
Why?
|
| Olfaction Disorders | 1 | 2006 | 12 | 0.250 |
Why?
|
| Mice | 5 | 2017 | 6644 | 0.250 |
Why?
|
| Synchrotrons | 1 | 2025 | 7 | 0.240 |
Why?
|
| Fertilizers | 1 | 2025 | 11 | 0.230 |
Why?
|
| Vacuum | 1 | 2025 | 6 | 0.230 |
Why?
|
| Nervous System Diseases | 1 | 2006 | 77 | 0.230 |
Why?
|
| Biological Availability | 1 | 2025 | 116 | 0.220 |
Why?
|
| Phosphorus | 1 | 2025 | 65 | 0.220 |
Why?
|
| Psychomotor Performance | 1 | 2006 | 159 | 0.220 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2025 | 388 | 0.210 |
Why?
|
| Linear Models | 2 | 2018 | 317 | 0.210 |
Why?
|
| Schizophrenic Psychology | 1 | 2003 | 16 | 0.200 |
Why?
|
| Mental Disorders | 2 | 2009 | 392 | 0.190 |
Why?
|
| Cognition Disorders | 1 | 2005 | 243 | 0.190 |
Why?
|
| Income | 1 | 2023 | 160 | 0.180 |
Why?
|
| Behavior, Animal | 2 | 2015 | 373 | 0.180 |
Why?
|
| Psychotic Disorders | 1 | 2003 | 71 | 0.180 |
Why?
|
| Syndrome | 3 | 2006 | 73 | 0.180 |
Why?
|
| Genetic Markers | 2 | 2013 | 150 | 0.180 |
Why?
|
| Siblings | 3 | 2006 | 22 | 0.170 |
Why?
|
| Analysis of Variance | 3 | 2009 | 575 | 0.170 |
Why?
|
| Brain | 3 | 2020 | 1472 | 0.170 |
Why?
|
| Mass Spectrometry | 2 | 2013 | 280 | 0.170 |
Why?
|
| Toxicology | 1 | 2020 | 8 | 0.160 |
Why?
|
| Residence Characteristics | 1 | 2023 | 363 | 0.160 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 31 | 0.150 |
Why?
|
| Mercury | 1 | 2018 | 39 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2019 | 456 | 0.130 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2016 | 38 | 0.120 |
Why?
|
| Health Status Disparities | 1 | 2023 | 719 | 0.120 |
Why?
|
| Environmental Health | 1 | 2016 | 43 | 0.120 |
Why?
|
| Urban Population | 1 | 2018 | 374 | 0.120 |
Why?
|
| United States | 3 | 2023 | 5205 | 0.120 |
Why?
|
| Adolescent | 4 | 2009 | 6081 | 0.120 |
Why?
|
| Macrophages | 1 | 2019 | 529 | 0.110 |
Why?
|
| Rotarod Performance Test | 1 | 2014 | 14 | 0.110 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2014 | 16 | 0.110 |
Why?
|
| Memory, Short-Term | 1 | 2014 | 59 | 0.110 |
Why?
|
| Sex Factors | 2 | 2009 | 1028 | 0.110 |
Why?
|
| Choice Behavior | 1 | 2014 | 93 | 0.100 |
Why?
|
| Hypertrophy | 1 | 2013 | 34 | 0.100 |
Why?
|
| Mesangial Cells | 1 | 2013 | 9 | 0.100 |
Why?
|
| Capillaries | 1 | 2013 | 27 | 0.100 |
Why?
|
| Reaction Time | 2 | 2005 | 157 | 0.100 |
Why?
|
| Podocytes | 1 | 2013 | 37 | 0.100 |
Why?
|
| Animals, Suckling | 1 | 2013 | 13 | 0.100 |
Why?
|
| Cell Size | 1 | 2013 | 46 | 0.100 |
Why?
|
| Sex Characteristics | 1 | 2015 | 258 | 0.100 |
Why?
|
| Dentate Gyrus | 1 | 2013 | 40 | 0.100 |
Why?
|
| Infant, Newborn | 1 | 2015 | 972 | 0.090 |
Why?
|
| Motor Activity | 1 | 2014 | 437 | 0.090 |
Why?
|
| Microchemistry | 1 | 2011 | 10 | 0.090 |
Why?
|
| Body Burden | 1 | 2011 | 7 | 0.090 |
Why?
|
| Blood Chemical Analysis | 1 | 2011 | 25 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 300 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2011 | 68 | 0.080 |
Why?
|
| Electrochemical Techniques | 1 | 2011 | 32 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2011 | 123 | 0.080 |
Why?
|
| Limit of Detection | 1 | 2011 | 94 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2013 | 549 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 95 | 0.080 |
Why?
|
| Personality Assessment | 1 | 2009 | 45 | 0.070 |
Why?
|
| Cytokines | 1 | 2013 | 678 | 0.070 |
Why?
|
| Age of Onset | 2 | 2006 | 114 | 0.070 |
Why?
|
| Iron | 1 | 2011 | 251 | 0.070 |
Why?
|
| Thinking | 1 | 2009 | 37 | 0.070 |
Why?
|
| Internal-External Control | 1 | 2009 | 63 | 0.070 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2009 | 116 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2013 | 1271 | 0.070 |
Why?
|
| Phenotype | 3 | 2006 | 780 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 1081 | 0.070 |
Why?
|
| Intelligence | 1 | 2006 | 15 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2013 | 1455 | 0.060 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 2006 | 2 | 0.060 |
Why?
|
| Psychometrics | 1 | 2009 | 358 | 0.060 |
Why?
|
| South Africa | 2 | 2004 | 38 | 0.060 |
Why?
|
| Mass Screening | 1 | 2011 | 541 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 236 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 138 | 0.060 |
Why?
|
| Blinking | 1 | 2005 | 14 | 0.060 |
Why?
|
| Child Behavior | 1 | 2006 | 81 | 0.060 |
Why?
|
| Stanford-Binet Test | 1 | 2005 | 1 | 0.060 |
Why?
|
| Craniofacial Abnormalities | 1 | 2005 | 24 | 0.060 |
Why?
|
| Acoustic Stimulation | 1 | 2005 | 78 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2005 | 282 | 0.050 |
Why?
|
| Disease Progression | 1 | 2006 | 667 | 0.050 |
Why?
|
| Adult | 5 | 2016 | 13872 | 0.050 |
Why?
|
| Hallucinations | 1 | 2003 | 11 | 0.050 |
Why?
|
| Delusions | 1 | 2003 | 8 | 0.050 |
Why?
|
| Cues | 1 | 2004 | 81 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 1063 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2006 | 1285 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2003 | 224 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2004 | 341 | 0.050 |
Why?
|
| Proline Oxidase | 1 | 2002 | 11 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 719 | 0.050 |
Why?
|
| Parents | 1 | 2006 | 370 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 1067 | 0.050 |
Why?
|
| Endpoint Determination | 1 | 2020 | 8 | 0.040 |
Why?
|
| Fear | 1 | 2003 | 272 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2020 | 74 | 0.040 |
Why?
|
| Models, Animal | 1 | 2020 | 151 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2002 | 430 | 0.040 |
Why?
|
| Proteins | 1 | 2002 | 382 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1997 | 15 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1997 | 93 | 0.030 |
Why?
|
| Mutation | 1 | 2002 | 1177 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 863 | 0.030 |
Why?
|
| New Mexico | 1 | 2016 | 37 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2004 | 3156 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2016 | 338 | 0.030 |
Why?
|
| Linkage Disequilibrium | 2 | 2004 | 86 | 0.020 |
Why?
|
| Quality of Life | 1 | 2016 | 616 | 0.020 |
Why?
|
| Middle Aged | 2 | 2016 | 12222 | 0.020 |
Why?
|
| Founder Effect | 1 | 2004 | 10 | 0.010 |
Why?
|
| Pedigree | 1 | 2004 | 94 | 0.010 |
Why?
|
| North America | 1 | 2004 | 85 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 8214 | 0.010 |
Why?
|
| Genetics, Population | 1 | 2004 | 121 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 2002 | 20 | 0.010 |
Why?
|
| Pseudogenes | 1 | 2002 | 12 | 0.010 |
Why?
|
| Africa | 1 | 2002 | 82 | 0.010 |
Why?
|
| Europe | 1 | 2002 | 115 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2002 | 78 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2002 | 91 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2002 | 272 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 352 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 333 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 1180 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 1542 | 0.010 |
Why?
|
| Hypertelorism | 1 | 1997 | 1 | 0.010 |
Why?
|
| Muscle Spasticity | 1 | 1997 | 3 | 0.010 |
Why?
|
| Blepharoptosis | 1 | 1997 | 4 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2002 | 1759 | 0.010 |
Why?
|